Article
Author(s):
Top articles of the week on The American Journal of Pharmacy Benefits.
FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis in Adults and Children
FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis in Adults and Children
2 Commerce Drive
Cranbury, NJ 08512